|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/00 | |
| C12N 9/88 | |||
| C12N 1/20 | |||
| C12N 15/00 | |||
| C07H 21/04 |
| (11) | Number of the document | 1928490 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06815505.0 |
| Date of filing the European patent application | 2006-09-26 | |
| (97) | Date of publication of the European application | 2008-06-11 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/037554 |
| Date | 2006-09-26 |
| (87) | Number | WO 2007/038548 |
| Date | 2007-04-05 |
| (30) | Number | Date | Country code |
| 720628 P | 2005-09-26 | US |
| (72) |
CAGGIANO, Anthony, O., US
IACI, Jennifer, US
VECCHIONE, Andrea, US
MARKENSOHN, Elizabeth, US
|
| (73) |
Acorda Therapeutics, Inc.,
420 Saw Mill River Road, Ardsley, NY 10502,
US
|
| (54) | COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS |
| COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS |